BNC Wealth Management LLC Invests $2.77 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

BNC Wealth Management LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 7,861 shares of the pharmaceutical company’s stock, valued at approximately $2,766,000. Vertex Pharmaceuticals comprises 1.5% of BNC […]

Related Keywords

United States ,America ,Sangeetan Bhatia ,Brucei Sachs , ,Bergankdv Wealth Management ,Grove Bank ,Vertex Pharmaceuticals ,Vertex Pharmaceuticals Profile ,Paradigm Financial Partners ,Wealth Management ,Quarter For Vertex Pharmaceuticals ,Bnc Wealth Management ,Vertex Pharmaceuticals Trading ,Insider Transactions At Vertex Pharmaceuticals ,Lincoln National Corp ,Parkside Financial Bank ,News Ratings For Vertex Pharmaceuticals Daily ,Canaccord Genuity Group ,Exchange Commission ,Vertex Pharmaceuticals Incorporated ,Free Report ,Financial Partners ,Financial Bank ,National Corp ,Director Bruce ,Director Sangeeta ,Genuity Group ,Pharmaceuticals Incorporated ,Get Free Report ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,